SCHEMBL3480596

SCHEMBL3480596

CC(C)(C)c1cc(OCCCO)ccc1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
ESRRA P11474 3/20 0.48
NR1I2 O75469 2/20 0.47
ALOX15 P16050 2/20 0.47
LMNA P02545 1/20 0.47
CYP2C9 P11712 1/20 0.47
MIF P14174 1/20 0.47
TYR P14679 1/20 0.47
HTT P42858 1/20 0.47
NFE2L2 Q16236 1/20 0.47
HSD17B10 Q99714 1/20 0.47
GAA P10253 2/20 0.47
ATM Q13315 2/20 0.47
XBP1 P17861 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NR1H4 Q96RI1 5/20 0.44
MAPT P10636 2/20 0.43
POLB P06746 1/20 0.43
ADRB2 P07550 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31216411 1.00 ALDH1A1 (0.51) ALDH1A1ESRRANR1I2ALOX15LMNA
SCHEMBL31216405 0.94 ALDH1A1 (0.49) ALDH1A1ESRRANR1I2ALOX15LMNA
SCHEMBL7823292 0.92 ALDH1A1 (0.53) ALDH1A1ESRRANR1I2ALOX15LMNA
SCHEMBL2815926 0.88 GAA (0.58) ALDH1A1ESRRANR1I2ALOX15LMNA
SCHEMBL38658565 0.86 ALDH1A1 (0.48) ALDH1A1ESRRANR1I2ALOX15LMNA
SCHEMBL9150850 0.85 ALDH1A1 (0.53) ALDH1A1ESRRANR1I2ALOX15LMNA
SCHEMBL3800346 0.84 NR5A1 (0.56) ALDH1A1ESRRANR1I2ALOX15LMNA
SCHEMBL9699885 0.84 NR5A1 (0.56) ALDH1A1ESRRANR1I2ALOX15LMNA
SCHEMBL11654654 0.84 NR5A1 (0.56) ALDH1A1ESRRANR1I2ALOX15LMNA
SCHEMBL224103 0.84 NR5A1 (0.56) ALDH1A1ESRRANR1I2ALOX15LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3578550-B1 NOVEL RED-SHIFTING BENZOTRIAZOLE UV ABSORBERS EVERLIGHT CHEM IND CORP (TW) 2023-08-16 EP disclosed
EP-3848357-B1 REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF EVERLIGHT CHEM IND CORP (TW) 2023-01-18 EP disclosed
US-20210214321-A1 NOVEL REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION (TW) 2021-07-15 US disclosed
EP-3848357-A1 REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF Everlight Chemical Industrial Corporation (TW) 2021-07-14 EP disclosed
EP-3578550-A1 NOVEL BENZOTRIAZOLE UV ABSORBER WITH RED SHIFT AND USE THEREOF Everlight Chemical Industrial Corporation (TW) 2019-12-11 EP disclosed
WO-2015072991-A1 UV-ABSORBERS FOR OPHTHALMIC LENS MATERIALS NOVARTIS AG (CH) 2015-05-21 WO disclosed
US-8585938-B1 UV-absorbers for ophthalmic lens materials NOVARTIS AG (CH) 2013-11-19 US disclosed
US-8585938-B1 UV-absorbers for ophthalmic lens materials NOVARTIS AG (CH) 2013-11-19 US disclosed
US-7803359-B1 UV-absorbers for ophthalmic lens materials ALCON, INC. (CH) 2010-09-28 US disclosed
EP-0274844-B1 ULTRAVIOLET ABSORBING POLYMERS COMPRISING 2-(2'-HYDROXY 5'-ACRYLOYLOXYALKOXYPHENYL)-2H-BENZOTRIAZOLE IOLAB CORPORATION (US) 1991-11-06 EP disclosed
US-4716234-A Ultraviolet absorbing polymers comprising 2-(2'-hydroxy-5'-acryloyloxyalkoxyphenyl)-2H-benzotriazole IOLAB CORPORATION (US) 1987-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210214321-A1 NOVEL REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF SULT1A1, XDH, SULT2A1 ALDH1A1 60/4885ESRRA 1319/4885NR1I2 236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.